Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.55% |
| 2 | Technology | 20.49% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
HBT Financial
HBT
$1.35B
| $997K | ﹤0.01% |
64,107
-12,793
| -17% | -$207K |
|
|
AGFS
2552
DELISTED
AgroFresh Solutions Inc
AGFS
| $996K | ﹤0.01% |
461,111
-281,713
| -38% | -$569K |
|
|
THR
2553
DELISTED
Thermon Group Holdings
THR
| $993K | ﹤0.01% |
57,388
-19,812
| -26% | -$329K |
|
2554
iShares MSCI USA Min Vol Factor ETF
USMV
$24.5B
| $992K | ﹤0.01% |
+13,500
| New | +$1.03M |
|
|
FRTX
2555
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
| $992K | ﹤0.01% |
30,618
-3,138
| -9% | -$102K |
|
|
LGO
2556
Largo
LGO
$74.2M
| $990K | ﹤0.01% |
+94,210
| New | +$1.32M |
|
|
VNE
2557
DELISTED
Veoneer, Inc.
VNE
| $990K | ﹤0.01% |
28,875
-25,894
| -47% | -$823K |
|
2558
BCE
BCE
$21.9B
| $986K | ﹤0.01% |
19,698
-36,400
| -65% | -$1.84M |
|
2559
Blue Ridge Bankshares
BRBS
$331M
| $985K | ﹤0.01% |
56,000
+23,300
| +71% | +$407K |
|
2560
Diageo
DEO
$53.2B
| $984K | ﹤0.01% |
+5,100
| New | +$988K |
|
|
DXYN
2561
DELISTED
Dixie Group Inc
DXYN
| $982K | ﹤0.01% |
202,100
-7,300
| -3% | -$28.5K |
|
|
GFED
2562
DELISTED
Guaranty Federal Bancshares In
GFED
| $981K | ﹤0.01% |
40,800
-500
| -1% | -$12.1K |
|
|
PRTK
2563
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $980K | ﹤0.01% |
201,624
-226,800
| -53% | -$1.25M |
|
2564
MGE Energy Inc
MGEE
$3.09B
| $978K | ﹤0.01% |
13,300
-2,200
| -14% | -$172K |
|
2565
Genworth Financial
GNW
$3.82B
| $976K | ﹤0.01% |
260,200
+209,165
| +410% | +$745K |
|
2566
iShares Europe ETF
IEV
$1.7B
| $975K | ﹤0.01% |
18,700
+7,900
| +73% | +$428K |
|
2567
Keros Therapeutics
KROS
$201M
| $972K | ﹤0.01% |
+24,572
| New | +$874K |
|
2568
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.93B
| $971K | ﹤0.01% |
+18,900
| New | +$984K |
|
|
MTCR
2569
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $971K | ﹤0.01% |
283,100
+203,200
| +254% | +$634K |
|
|
HYPD
2570
Hyperion DeFi Inc
HYPD
$41.4M
| $969K | ﹤0.01% |
2,473
+609
| +33% | +$226K |
|
|
ATXS
2571
DELISTED
Astria Therapeutics
ATXS
| $967K | ﹤0.01% |
109,353
+46,443
| +74% | +$445K |
|
2572
Twin Disc
TWIN
$353M
| $967K | ﹤0.01% |
90,693
+7,500
| +9% | +$98K |
|
|
MREO
2573
Mereo BioPharma
MREO
$51.5M
| $965K | ﹤0.01% |
398,900
+113,800
| +40% | +$301K |
|
2574
Solid Biosciences
SLDB
$981M
| $960K | ﹤0.01% |
26,790
+1,138
| +4% | +$48.3K |
|
|
SOGP
2575
Sound Group
SOGP
$47.2M
| $959K | ﹤0.01% |
30,238
-54,080
| -64% | -$2.43M |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.